מרופנם אנפארם 500 מג

Valsts: Izraēla

Valoda: ivrits

Klimata pārmaiņas: Ministry of Health

Aktīvā sastāvdaļa:

MEROPENEM AS TRIHYDRATE

Pieejams no:

K.S.KIM INTERNATIONAL (SK- PHARMA) LTD., ISRAEL

ATĶ kods:

J01DH02

Zāļu forma:

אבקה להמסה להזרקה\אינפוזיה

Kompozīcija:

MEROPENEM AS TRIHYDRATE 500 MG/VIAL

Ievadīšanas:

תוך-ורידי

Receptes veids:

מרשם נדרש

Ražojis:

ANFARM HELLAS S.A., GREECE

Ārstniecības grupa:

MEROPENEM

Ārstniecības joma:

MEROPENEM

Ārstēšanas norādes:

Meropenem is indicated for treatment in adults and children of the following severe infections caused by single or multiple susceptible bacteria sensitive to meropenem: - Pneumonias and nosocomial pneumonias. - Pulmonary infections in patients with cystic fibrosis. - Urinary tract infections. - Intra-abdominal infections. - Gynecological infections such as endometritis and pelvic inflammatory disease. - Skin and skin structure infections. - Meningitis -Septicemia. Meropenem has proved efficacious alone or in combination with other antimicrobial agents in the treatment of polymicrobial infections. There is no experience in pediatric patients with neutropenia or primary or secondary immunodeficiency

Autorizācija datums:

2018-07-31